J. Allen D. Cooper, Jr., MD

Pulm_Div_Cooper

 


Professor of Medicine

Chief, Pulmonary Section, Department of Veterans Affairs

Medical Director, Respiratory Therapy, Department of Veterans Affairs

Division of Pulmonary, Allergy & Critical Care Medicine
1720 2nd Avenue So, THT-422
University of Alabama at Birmingham
Birmingham, AL 35294

 

Board Certifications
1981, American Board of Internal Medicine
1984, American Board of Internal Medicine, Pulmonary Diseases
1989, American Board of Internal Medicine, Critical Care Medicine

Medical School:  Duke University, Durham, N.C., 1974-1978

Internship:  University of Washington Affiliated Hospitals, Seattle WA, 1978-1979 

Residency:  University of Virginia Medical Center, Charlottesville, VA, 1979-1981

Fellowship:  Yale University School of Medicine, New Haven, CT, 1981-1985

Contact Information

   

Campus Address:

 

 THT 422

Academic Office location:

 

 VAMC 6-C-125

Office Phone:

 

 (205) 934-1339

Office Fax (Academic):

 

 (205) 934-1721

TKC Clinic Phone:

 

 (205) 801-7545

TKC Clinic Fax:

 

 (205) 802-8231

Email Address:

 

 allenc@uab.edu

Beeper #:

 

 6813

Office Assistant:

Christy Shinn
cshinn@uab.edu
Phone: (205) 975-8978
Fax: (205) 934-1721

Brief Bio

Dr. Allen Cooper completed his undergraduate studies at Northwestern University. He completed his medical degree at Duke University in 1978. His postgraduate training included an internship at the University of Washington, a residency at the University of Virginia and fellowship in pulmonary/critical care medicine at Yale University. He joined the Yale faculty in 1985 and had risen to the rank of Assistant Professor of Medicine prior to coming to the University of Alabama at Birmingham in 1988. Since coming to UAB Dr. Cooper has received continuous funding in both basic and clinical research. He has also been involved in administrative duties including Pulmonary Section Chief/Respiratory Therapy Medical Director at the Birmingham VA as well as Director of the Fellowship in Pulmonary and Critical Care Medicine since 1998.  He currently is funded through the NIH for clinical research in patients with chronic obstructive pulmonary disease (COPD).

 

Clinical Interests 

Chronic Obstructive Pulmonary Disease

Asthma due to occupational and other environmental exposures

Drug induced pulmonary disease

Academic & Research Interests

Dr. Cooper was initially involved with basic science research when he came to UAB.  This research focused on control of acute lung inflammation. He subsequently has transitioned to clinical research focused on treatment of patients with COPD. He is principal investigator for the Long term Oxygen Treatment Trial (LOTT) funded through the NIH and is co-PI on the NIH funded COPD Clinical Research Network. He is also Local Site Investigator examining efficacy of corticosteroids in severe community acquired pneumonia funded by the VA Cooperative Studies Program.  He is PI currently and in the past on numerous industry-funded clinical trials as well.

 

Key Publications

1. Cooper JAD Jr, Merrill WW, Buck MG, Schachter EN. The relationship between bronchoalveolar neutrophil recruitment and bronchoconstriction induced by a soluble extract of cotton bracts. Am Rev Respir Dis 1986;134:975-82

2. Cooper JAD Jr, Zitnik R, Care S, Buck MG, Merrill WW. Isolation of an inhibitor of neutrophil function from bronchial lavage of normal volunteers: Relationship to bronchoconstriction and airway inflammation. Am J Physiol 1991; 260:L501-L509

3. Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JAD Jr, Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator. Ann Int Med 2005; 143:317-26

4. Cooper JAD Jr. Occupational asthma, byssinosis, and industrial bronchitis. In: Pulmonary Diseases and Disorders 4th Edition. Fishman AP, Editor-in-Chief, 2008

5. Gauhar U, Dransfield M, Cooper JAD Jr. Sequential comparison of tiotropium to high dose ipratropium in patients with chronic obstructive pulmonary disease in a practice setting. International Journal of COPD 2009:4;1-5

SOM Epilogue Menu